


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-5.65%
+0.64%
+3.34%
+0.45%
MESO
Mesoblast Limited
$15.37
Chart
$16.73 (-8.13%)
$13.82 (+11.22%)
$10.68 (+43.91%)
$11.09 (+38.59%)
MESO has High risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Low volume

MESO overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
MESO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MESO Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is MESO current stock price?
What are MESO stock strengths?
What is MESO Risk Level?
What is MESO market cap and volume?
What is MESO current Stock IQ?
Should I buy MESO stock right now?
Is MESO a Strong Buy right now?
What does a 'Strong Buy' rating mean for MESO?
What does a 'Strong Sell' rating mean for MESO?
What factors influence MESO's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-5.65%
+0.64%
+3.34%
+0.45%
MESO
Mesoblast Limited
Current Price
$15.37
Stock Insights
Not Enough Information

Chart
$16.73 (-8.13%)
$13.82 (+11.22%)
$10.68 (+43.91%)
$11.09 (+38.59%)
MESO Analysts Opinion
MESO Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
MESO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MESO Street Sentiment is extremely bullish and have positive views on the near-term outlook
MESO has High risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Low volume

Average key support and resistance price levels.
MESO Latest Analysis
Mesoblast Appoints James M OBrien New CFO . (RTTNews) - Mesoblast Ltd. (MESO MSB.AX) an Australian regenerative medicine company Monday announced the appointment of James M OBrien as its US-based Chief Financial Officer or CFO. The company said that the appointment was done as part of its transition to a fully integrat
Mon Nov 17, 2025
Mesoblast appoints James M. OBrien as US-based CFO.
Mon Nov 17, 2025
James M. OBrien Appointed Chief Financial Officer at Mesoblast. ASX:MSB)) global leader in allogeneic cellular medicines for inflammatory diseases today announced that in connection with the Company'.s transition to a fully integrated commercial organization it has appointed James M. O'.Brien as its US-based Chief Financial Officer (CFO). Jim has extensive experience in all aspects of financial management and planning having spent the majority of his career with multi-national public an
Mon Nov 17, 2025
James M. OBrien Appointed Chief Financial Officer at Mesoblast.
Mon Nov 17, 2025
Bears are Losing Control Over Mesoblast Limited (MESO) Heres Why Its a Buy Now. After losing some value lately a hammer chart pattern has been formed for Mesoblast Limited (MESO) indicating that the stock has found support. This combined with an upward trend in earnings estimate revisions could lead to a trend reversal for the stock in the near term.
Mon Nov 10, 2025
Mesoblast Breaks Below 200-Day Moving Average - Notable for MESO. In trading on Friday shares of Mesoblast Ltd (Symbol: MESO) crossed below their 200 day moving average of $14.27 changing hands as low as $14.14 per share. Mesoblast Ltd shares are currently trading down about 5.2% on the day. The chart below shows the one year performance o
Fri Nov 7, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MESO Stock trends
MESO Stock performance
MESO Stock analysis
MESO investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.